Jacobi Capital Management LLC Adma Biologics, Inc. Transaction History

Jacobi Capital Management LLC

  • $1.3 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$1.51 - $2.07 $1,208 - $1,655
-800 Closed
0 $0
Q1 2021

May 11, 2021
SELL
$1.67 - $2.95 $2,171 - $3,835
-1,300 Reduced 61.9%
800 $1,000
Q4 2020

Feb 08, 2021
BUY
$1.8 - $2.56 $900 - $1,280
500 Added 31.25%
2,100 $4,000
Q3 2020

Oct 30, 2020
BUY
$2.04 - $3.74 $3,264 - $5,984
1,600 New
1,600 $4,000

Others Institutions Holding ADMA

# of Institutions
339
Shares Held
182M
Call Options Held
1.72M
Put Options Held
846K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.05B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email